Skip to main content
See every side of every news story
Published loading...Updated

Trump FDA Nominee Heidi Overton Faces Senate Questions on Mifepristone, Vaccines

Senators are expected to press her on mifepristone, vaccines and whether she will keep FDA decisions independent from Trump and Kennedy.

  • On Thursday, President Donald Trump's FDA nominee Dr. Heidi Overton faces a Senate confirmation hearing, with lawmakers expected to press her on plans for vaccines and the abortion pill mifepristone.
  • Overton, a former America First Policy Institute executive, is a proponent of Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" movement, signaling alignment with the administration's medical priorities.
  • Senator Bill Cassidy has questioned her suitability to manage the FDA's 16,000 staffers, citing her lack of experience running a large bureaucracy and arguing the nomination prioritizes political opinions over qualifications.
  • To secure the nomination, Overton needs a majority vote from the 21-member Senate Health Committee; Republicans continue pressuring the FDA to restrict access to mifepristone, the abortion pill used in most U.S. abortions.
  • Overton inherits an agency that has lost about 20% of its employees since President Trump took office; she plans to emphasize "go fast" on clinical trials to compete with China's biotechnology industry.
Insights by Ground AI

14 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 42% of the sources lean Left, 42% of the sources are Center
42% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Washington Times broke the news in Washington, United States on Wednesday, September 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal